Keywords: glaxo, wellcome, first-quarter, sales, climb, lotronex, starts

Glaxo Wellcome first-quarter sales climb 13%, Lotronex starts well in the

Article | 20 April 2000

Print This

Issuing a perfunctory statement, Glaxo Wellcome has announced a salesrise of 13% (at constant exchange rates) for the first quarter of 2000, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in